Opinion statement
Sleep-related eating disorder (SRED) is classified as an NREM-related parasomnia characterized by recurrent episodes of dysfunctional eating that occur after an arousal from the main sleep period with partial or complete amnesia for the event, resulting in weight gain from eating high calorie foods and causing various injuries due to consumption of inedible or toxic items. SRED can be idiopathic or commonly associated with other primary sleep disorders such as sleepwalking, restless legs syndrome (RLS), obstructive sleep apnea syndrome (OSAS), other clinical conditions, or use of sedative-hypnotic medications. First-line treatment of idiopathic SRED includes selective serotonin reuptake inhibitors (SSRIs) at mean dosages of 20 to 30 mg/day. Topiramate at 100–300 mg/day and clonazepam at 0.5–2.0 mg/day can be valid alternative options. SRED related to other parasomnias or sleep disturbances that cause sleep fragmentation benefit most from treatment of the associated sleep disorder. In particular, RLS-related SRED is best treated with dopamine agonists such as pramipexole, while sleepwalking-related SRED benefits from low-dose benzodiazepines such as clonazepam. Different kinds of drug associations have been proposed in a limited number of cases, especially in the past. We strongly recommend that all patients suffering from SRED should undergo consistent and regular follow-up about 2–3 times per year or otherwise according to the physician’s judgment, in order to assess the evolution of symptom severity and frequency and re-evaluate treatment efficacy and any side effects that may arise.
Similar content being viewed by others
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Schenck CH, Hurwitz TD, Bundlie SR, Mahowald MW. Sleep-related eating disorders: polysomnographic correlates of a heterogeneous syndrome distinct from daytime eating disorders. Sleep. 1991;14(5):419–31. First complete description of clinical manifestaion of SRED.
Stunkard AJ, Grace WJ, Wolff HG. The night-eating syndrome; a pattern of food intake among certain obese patients. Am J Med. 1955;19(1):78–86.
Allison KC, Lundgren JD, O’Reardon JP, Geliebter A, Gluck ME, Vinai P, et al. Proposed diagnostic criteria for night eating syndrome. Int J Eat Disord. 2010;43(3):241–7. doi:10.1002/eat.20693. Most updated diagnostic criteria for NES since its first description by Stunkard et al. 1955.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5 2013.
Howell MJ, Schenck CH, Crow SJ. A review of nighttime eating disorders. Sleep Med Rev. 2009;13(1):23–34. doi:10.1016/j.smrv.2008.07.005.
Auger RR. Sleep-related eating disorders. Psychiatry. 2006;3(11):64–70.
Provini F, Albani F, Vetrugno R, Vignatelli L, Lombardi C, Plazzi G, et al. A pilot double-blind placebo-controlled trial of low-dose pramipexole in sleep-related eating disorder. Eur J Neurol. 2005;12(6):432–6. First study objectively evaluating the efficacy of pramipexole in SRED.
Vetrugno R, Manconi M, Ferini-Strambi L, Provini F, Plazzi G, Montagna P. Nocturnal eating: sleep-related eating disorder or night eating syndrome? A videopolysomnographic study. Sleep. 2006;29(7):949–54. Full videopolysomnographic description of neurophysiological aspects of nocturnal eating in a large population.
American Academy of Sleep Medicine. International classification of sleep disorders. 3rd ed. Darien, IL: American Academy of Sleep Medicine; 2014. The latest and most updated classification of sleep disorders.
Spaggiari MC, Granella F, Parrino L, Marchesi C, Melli I, Terzano MG. Nocturnal eating syndrome in adults. Sleep. 1994;17(4):339–44. One of the main descriptions of videopolysomnographic findings in a NES population referring to a sleep disorder center.
Inoue Y. Sleep-related eating disorder and its associated conditions. Psychiatry Clin Neurosci. 2014. doi:10.1111/pcn.12263.
Schenck CH, Mahowald MW. Review of nocturnal sleep-related eating disorders. Int J Eat Disord. 1994;15(4):343–56.
Winkelman JW, Johnson EA, Richards LM. Sleep-related eating disorder. Handb Clin Neurol. 2011;98:577–85. Comprehensive review of SRED.
Perogamvros L, Baud P, Hasler R, Cloninger CR, Schwartz S, Perrig S. Active reward processing during human sleep: insights from sleep-related eating disorder. Front Neurol. 2012;3:168.
Benca RM. Diagnosis and treatment of chronic insomnia: a review. Psychiatr Serv. 2005;56(3):332–43.
Winkelman JW. Clinical and polysomnographic features of sleep-related eating disorder. J Clin Psychiatry. 1998;59(1):14–9.
Lu ML, Shen WW. Sleep-related eating disorder induced by risperidone. J Clin Psychiatry. 2004;65(2):273–4.
Paquet V, Strul J, Servais L, Pelc I, Fossion P. Sleep-related eating disorder induced by olanzapine. J Clin Psychiatry. 2002;63(7):597.
Schenck CH, Hurwitz TD, O’Connor KA, Mahowald MW. Additional categories of sleep-related eating disorders and the current status of treatment. Sleep. 1993;16(5):457–66. First complete description of clinical manifestaion of SRED and first therapeutical protocols.
Hoque R, Chesson Jr AL. Zolpidem-induced sleepwalking, sleep related eating disorder, and sleep-driving: fluorine-18-flourodeoxyglucose positron emission tomography analysis, and a literature review of other unexpected clinical effects of zolpidem. J Clin Sleep Med. 2009;5(5):471–6.
Nzwalo H, Ferreira L, Peralta R, Bentes C. Sleep-related eating disorder secondary to zolpidem. BMJ Case Reports. February 21, 2013; doi:10.1136/bcr-2012-008003.
Wing YK, Lam SP, Li SX, Zhang J, Yu MW. Sleep-related eating disorder and zolpidem: an open interventional cohort study. J Clin Psychiatry. 2010;71(5):653–6.
Santin J, Mery V, Elso MJ, Retamal E, Torres C, Ivelic J, et al. Sleep-related eating disorder: a descriptive study in Chilean patients. Sleep Med. 2014;15(2):163–7.
Miyaoka T, Yasukawa R, Tsubouchi K, Miura S, Shimizu Y, Sukegawa T, et al. Successful treatment of nocturnal eating/drinking syndrome with selective serotonin reuptake inhibitors. Int Clin Psychopharmacol. 2003;18(3):175–7.
Winkelman JW. Treatment of nocturnal eating syndrome and sleep-related eating disorder with topiramate. Sleep Med. 2003;4(3):243–6.
Martinez-Salio A, Soler-Algarra S, Calvo-Garcia I, Sanchez-Martin M. Nocturnal sleep-related eating disorder that responds to topiramate. Rev Neurol. 2007;45(5):276–9.
Winkelman JW. Efficacy and tolerability of open-label topiramate in the treatment of sleep-related eating disorder: a retrospective case series. J Clin Psychiatry. 2006;67(11):1729–34. Confirmation of topiramate efficacy in treating SRED.
Howell MJ, Schenck CH. Treatment of nocturnal eating disorders. Curr Treat Options Neurol. 2009;11(5):333–9. Updated and comprehensive review of the state-of-the-art SRED treatment options.
Schenck CH, Mahowald MW. Combined bupropion-levodopa-trazodone therapy of sleep-related eating and sleep disruption in two adults with chemical dependency. Sleep. 2000;23(5):587–8.
Kobayashi N, Yoshimura R, Takano M. Successful treatment with clonazepam and pramipexole of a patient with sleep-related eating disorder associated with restless legs syndrome: a case report. Case Rep Med. 2012;2012:893681.
Antelmi E, Vinai P, Pizza F, Marcatelli M, Speciale M, Provini F. Nocturnal eating is part of the clinical spectrum of restless legs syndrome and an underestimated risk factor for increased body mass index. Sleep Med. 2014;15(2):168–72.
Provini F, Antelmi E, Vignatelli L, Zaniboni A, Naldi G, Calandra-Buonaura G, et al. Association of restless legs syndrome with nocturnal eating: a case–control study. Mov Disord. 2009;24(6):871–7. First findings of a new association between eating disorders and RLS.
Heathman JC, Neal DW, Thomas CR. Sleep-related eating disorder associated with quetiapine. J Clin Psychopharmacol. 2014;34(5):658–60.
Jeong JH, Bahk WM. Sleep-related eating disorder associated with mirtazapine. J Clin Psychopharmacol. 2014;34(6):752–3.
Wallace DM, Maze T, Shafazand S. Sodium oxybate-induced sleep driving and sleep-related eating disorder. J Clin Sleep Med. 2011;7(3):310–1.
Brion A, Flamand M, Oudiette D, Voillery D, Golmard JL, Arnulf I. Sleep-related eating disorder versus sleepwalking: a controlled study. Sleep Med. 2012;13(8):1094–101. A confirmation of the commonalities between SRED as a specialized form of sleepwalking.
Wilkes JJ, Nelson E, Osborne M, Demarest KT, Olefsky JM. Topiramate is an insulin-sensitizing compound in vivo with direct effects on adipocytes in female ZDF rats. Am J Physiol Endocrinol Metab. 2005;288(3):E617–24.
Liang Y, Chen X, Osborne M, DeCarlo SO, Jetton TL, Demarest K. Topiramate ameliorates hyperglycaemia and improves glucose-stimulated insulin release in ZDF rats and db/db mice. Diabetes Obes Metab. 2005;7(4):360–9.
Schenck CH, Mahowald MW. Topiramate therapy of sleep related eating disorder. Sleep 2006;29:A268.
Compliance with Ethics Guidelines
Conflict of Interest
Giacomo Chiaro and Maria Turchese Caletti declare no conflicts of interest.
Federica Provini declares the receipt of personal fees from MedaPharma, outside the submitted work.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Sleep Disorders
Rights and permissions
About this article
Cite this article
Chiaro, G., Caletti, M.T. & Provini, F. Treatment of Sleep-Related Eating Disorder. Curr Treat Options Neurol 17, 33 (2015). https://doi.org/10.1007/s11940-015-0361-6
Published:
DOI: https://doi.org/10.1007/s11940-015-0361-6